Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Director · President, CEO | August 11, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date August 11, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,201,814 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Sale · Disposed 28,800 · Balance 1,201,814 F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,281 | $66.89 | $85,690.57 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602,637 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.57, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 8,710 | $65.57 | $571,082.47 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,918 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.23, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 16,427 | $64.94 | $1,066,798.95 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,628 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.34, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 38,545 | $3.24 | $124,885.80 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 26,418 | $2.40 | $63,403.20 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 56,916 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · derivative · entry 8 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,418 Underlying: Common Stock · 56,916 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F7 · derivative.exercise_date: 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 8,334 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · derivative · entry 7 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,334 shares Expires 2022-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F6 · derivative.exercise_date: 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 6,910 | $80.66 | $557,377.18 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · nonDerivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,092 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.32 to $81.15, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 25,167 | $79.81 | $2,008,563.17 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · nonDerivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,002 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.32 to $80.31, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 22,554 | $78.73 | $1,775,568.16 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 596,169 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.32 to $79.29, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 10,619 | $77.97 | $827,996.35 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,723 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.32 to $78.30, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 56,916 | $2.40 | $136,598.40 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 01:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 8,334 | $2.28 | $19,001.52 |
DisclosureSEC source: 0001104659-21-138335 · tm2132741-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 20:45 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 540 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-21-090681 · tm2121889-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 656,064 Underlying: Common Stock · 540 shares Expires 2025-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of 827,000 options originally granted vested on the 19th of each month for forty-eight months beginning August 19, 2015. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 20:45 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 540 | $5.00 | $2,700.00 |
DisclosureSEC source: 0001104659-21-090681 · tm2121889-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 21:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 70,396 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-21-085242 · tm2120656-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 656,604 Underlying: Common Stock · 70,396 shares Expires 2025-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of 827,000 options originally granted vested on the 19th of each month for forty-eight months beginning August 19, 2015. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 21:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 70,396 | $5.00 | $351,980.00 |
DisclosureSEC source: 0001104659-21-085242 · tm2120656-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:08 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantRestricted Stock Rights · Derivative | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-035157 · tm219529d1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. F3 · derivative.expiration_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:08 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 66,000 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-21-035157 · tm219529d1_4seq1.xml · derivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 Underlying: Common Stock · 66,000 shares Expires 2028-03-09 F1 · derivative.exercise_date: 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 22:18 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 11,560 | $0.00 Strike: $8.65 | $0.00 |
DisclosureSEC source: 0001104659-20-140606 · tm2039628d1_4seq1.xml · derivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,560 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the 290,000 options originally granted vested on the 28th of each month beginning on March 28, 2018. On September 30, 2019, 24/48 of the 290,000 options originally granted automatically vested under the terms of such due to the Issuer meeting certain financial performance criteria. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 22:18 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 80,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-20-140606 · tm2039628d1_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,936 Underlying: Common Stock · 80,000 shares Expires 2025-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of the 827,000 options originally granted vested on the 19th of each month beginning on August 19, 2015. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 22:18 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 11,560 | $8.65 | $99,994.00 |
DisclosureSEC source: 0001104659-20-140606 · tm2039628d1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 22:18 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 80,000 | $5.00 | $400,000.00 |
DisclosureSEC source: 0001104659-20-140606 · tm2039628d1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 21:20 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 375,000 | $0.00 Strike: $16.93 | $0.00 |
DisclosureSEC source: 0001104659-20-041950 · tm2014753d3_form4.xml · derivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2030-03-30 F1 · derivative.exercise_date: 1/48 of options vest on the 30th of each month for forty-eight months beginning 4/30/2020. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 23:29 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 3,033 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-20-012097 · tm206985-1_4.xml · derivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,667 Underlying: Common Stock · 3,033 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/48 of the 387,501 options originally granted vest on the 18th of each month for forty-eight months beginning on January 18, 2015. F4 · balance_after: The number of derivative shares beneficially owned following reported transaction has been adjusted to take into account the 1-for-12 reverse stock split effective as of May 19, 2015. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 23:29 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 58,781 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001104659-20-012097 · tm206985-1_4.xml · derivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,219 Underlying: Common Stock · 58,781 shares Expires 2027-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the 340,000 options originally granted vest on the 23rd of each month for forty-eight months beginning on May 23, 2017. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 23:29 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 22,517 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-20-012097 · tm206985-1_4.xml · derivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,007 Underlying: Common Stock · 22,517 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of the 280,000 options originally granted vest on the 6th of each month for forty-eight months beginning on May 6, 2016. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 23:29 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 3,033 | $4.80 | $14,558.40 |
DisclosureSEC source: 0001104659-20-012097 · tm206985-1_4.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 23:29 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 58,781 | $3.44 | $202,206.64 |
DisclosureSEC source: 0001104659-20-012097 · tm206985-1_4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 23:29 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 22,517 | $1.87 | $42,106.79 |
DisclosureSEC source: 0001104659-20-012097 · tm206985-1_4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 22:11 UTC | Cryoport, Inc. CYRX · Entity 5125 | PurchaseCommon Stock | 3,356 | $14.00 | $46,984.00 |
DisclosureSEC source: 0001104659-19-064335 · tm1922882-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,265 Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:23 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 375,000 | $0.00 Strike: $12.79 | $0.00 |
DisclosureSEC source: 0001144204-19-018089 · tv518161_4.xml · derivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2029-04-01 F1 · derivative.exercise_date: 1/48 of options vest on the 1st of each month for forty-eight months beginning 4/01/2019. Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 01:56 UTC | Cryoport, Inc. CYRX · Entity 5125 | OtherWarrant to Purchase Common Stock · Derivative | 10,321 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001144204-19-013585 · tv516103_4.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,321 shares Expires 2019-03-31 F1 · derivative.exercise_date: Warrants to purchase 7,543 shares were exercisable on May 6, 2014 and warrants to purchase 2,778 shares were exercisable on November 17, 2014, in each case, the date of issuance. Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 01:56 UTC | Cryoport, Inc. CYRX · Entity 5125 | OtherCommon Stock | 10,321 | $6.00 | $61,926.00 |
DisclosureSEC source: 0001144204-19-013585 · tv516103_4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,909 Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | OtherWarrant to Purchase Common Stock · Derivative | 5,001 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · derivative · entry 9 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,001 shares Expires 2018-12-31 F5 · derivative.exercise_date: Warrants to purchase 2,917 shares were exercisable on December 11, 2013 and warrants to purchase 2,084 shares were exercisable on January 10, 2014, in each case, the date of issuance. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · derivative · entry 8 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,000 Underlying: Common Stock · 20,000 shares Expires 2025-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/48 of the 827,000 options originally granted vest on the 19th of each month for forty-eight months beginning on August 19, 2015. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,300 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · derivative · entry 7 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,700 Underlying: Common Stock · 1,300 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/48 of the 387,501 options originally granted vest on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,938 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · derivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,524 Underlying: Common Stock · 2,938 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the 280,000 options originally granted vest on the 6th of each month for forty-eight months beginning on May 6, 2016. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,252 | $13.06 | $29,411.12 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · nonDerivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,588 F1 · kind: The reporting person exercised a warrant to purchase 5,001 shares for $5.88 per share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 2,749 shares to pay the exercise price and issuing to the reporting person the remaining 2,252 shares. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | OtherCommon Stock | 5,001 | $5.88 | $29,405.88 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,840 Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 20,000 | $5.00 | $100,000.00 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 1,300 | $4.80 | $6,240.00 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,938 | $1.87 | $5,494.06 |
DisclosureSEC source: 0001144204-18-034269 · tv496517_4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 18:14 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to Purchase Common Stock · Derivative | 290,000 | $0.00 Strike: $8.65 | $0.00 |
DisclosureSEC source: 0001144204-18-018221 · tv489934_4.xml · derivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,000 Underlying: Common Stock · 290,000 shares Expires 2028-03-28 F1 · derivative.exercise_date: 1/48 of the option vests on the 28th of each month for forty-eight months beginning on March 28, 2018. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 17:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to Purchase Common Stock · Derivative | 16,501 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001144204-18-017852 · tv489854_form4.xml · derivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,000 Underlying: Common Stock · 16,501 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the 387,501 options originally granted vest on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 17:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to Purchase Common Stock · Derivative | 21,538 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001144204-18-017852 · tv489854_form4.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,462 Underlying: Common Stock · 21,538 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of the 280,000 options originally granted vest on the 6th of each month for forty-eight months beginning on May 6, 2016. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 17:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 16,501 | $4.80 | $79,204.80 |
DisclosureSEC source: 0001144204-18-017852 · tv489854_form4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 17:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 21,538 | $1.87 | $40,276.06 |
DisclosureSEC source: 0001144204-18-017852 · tv489854_form4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 01:42 UTC | Cryoport, Inc. CYRX · Entity 5125 | OtherWarrant to purchase common stock · Derivative | 80,558 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0001144204-18-015048 · tv488675_4.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,558 shares Expires 2020-07-29 Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 01:42 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 29,257 | $9.83 | $287,596.31 |
DisclosureSEC source: 0001144204-18-015048 · tv488675_4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,562 F2 · kind: The reporting person exercised a warrant to purchase 80,558 shares for $3.57 per share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 29,257 shares to pay the exercise price and issuing to the reporting person the remaining 51,301 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.